Jenny Kobin | Head, IR |
George Lasezkay | President and CEO |
Thomas Ciulla | CMO and Chief Development Officer |
Charles Deignan | CFO |
Andreas Argyrides | Wedbush Securities |
Annabel Samimy | Stifel |
Jonathan Wolleben | JMP Securities |
Greetings, and welcome to the Clearside Biomedical Fourth Quarter and Year-End Financial Results and Corporate Update Conference Call.
As a reminder, this conference call is being recorded. I would now like to introduce your host, Jenny Kobin, Clearside, Investor Relations. Please go ahead.
Good afternoon, everyone, and thank you for joining us on the call today.